Corinne John

BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland.

Redalpine Venture Parners AG (Redalpine) is an independent venture capital investment firm headquartered in Zurich, Switzerland. The firm was founded in 2006.

Creoptix AG provides biosensor devices for applications in drug discovery. It specializes in optical instruments and consumables for the label-free analysis of molecular interactions for the drug discovery. The firm’s products include instruments, sensors, and software. The company was founded by Kaspar Cottier in 2009 and is headquartered in Wadenswil, Switzerland.

YouRehab AG creates interactive therapy systems for neurological motor disorders. It offers YouGrabber, an all-in-one upper limb rehabilitation product for arms and fingers, which trains patients at peak intensity using rehabilitation gaming to enahcne clinical outcomes; YouKicker, a lower limb rehabilitation product for legs and feet. The company was founded by Oliver Ullmann, Kynan Eng, Edith Chevrier, Lisa Holper, Daniel Kiper, Pawal Pyk and Ewa Siekierka in April 2010 and is headquartered in Schlieren, Switzerland.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999.

ACREDIS qmc AG engages in the provision of project and quality management, marketing, procurement, logistics, and distribution services for the healthcare, hotel, and restaurant service providers focusing on consumer and durable goods. It also acquires participating interests in firms, as well as acquires, manages, and sells licenses, patents, and other intangible assets. The company was founded by Stephan Hägeli on February 22, 2006 and is headquartered in Zurich, Switzerland.

Versantis AG develops liver disease therapeutics and diagnostics. Its pipeline include VS-01, a drug to support liver, brain, and kidneys; VS-02 and VS-03 that are solutions for chronic liver diseases and treatment of drug intoxications; and other products for the treatment of metabolic academia and diagnosis of hyperammonemia. The company was founded by Vincent Forster and Meriam Kabbaj in 2015 and is headquartered in Zurich, Switzerland.

Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland.

MedMira Holding AG operates as a holding company with interests in developing and manufacturing medical diagnostics and technologies. The firm provides medical progress to customers from all over the world while combining the quality with economical sustainability. The company was founded on December 22, 2008 and is headquartered in Zug, Switzerland.

Lunaphore Technologies SA develops tissue diagnostics solutions. Its products include in vitro diagnostics, automated staining instruments, and consumables. The company was founded by Ata Tuna Ciftlik, Diego Gabriel Dupouy, and D?borah Heintze in April 2014 and is headquartered in Tolochenaz, Switzerland.

Part of The Boston Consulting Group, Inc., Boston Consulting Group Holding AG operates as a holding Swiss company. The company is based in Zurich, Switzerland. Founded in 1963.

Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland.